| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Physiology and Internal Medicine, Virginia Commonwealth University, Richmond, Virginia 23298–0551
Dehydroepiandrosterone (DHEA), an adrenal cortex hormone secreted in large quantities in humans, protects cells of the clonal mouse hippocampal cell line HT-22 against the excitatory amino acid glutamate (5 mM), and amyloid ß-protein (2 µM) toxicity in a dose-dependent manner with optimum protection obtained at 5 µM concentration of DHEA. The protective effects of DHEA appear to be specific in that other related steroids and metabolites of DHEA, such as 5-androstene-3ß,17ß-diol, etiocholan-3
-ol-17-one, etiocholan-3ß-ol-17-one, testosterone, and 5-androstane-3,17-dione, offered no protection even at 50 µM concentrations. In addition, using immunocytochemical techniques, we observed that 20 hr of treatment with 5 mM glutamate remarkably increased glucocorticoid receptor (GR) nuclear localization in neuronal cells. Interestingly, 5 µM DHEA treatment for 24 hr, followed by 5 mM glutamate treatment for 20 hr almost completely reversed the copious nuclear localization of GR observed by glutamate treatment alone. Results obtained suggest that DHEA protects hippocampal neurons, at least in part, by its antiglucocorticoid action via decreasing hippocampal cells nuclear GR levels.
This article has been cited by other articles:
|
|
 |
|
  S. A. McIsaac, A. Westrin, and A. H. Young Antiglucocorticoids in psychiatry Advan. Psychiatr. Treat., July 1, 2009; 15(4): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Naylor, C. M. Hulette, D. C. Steffens, L. J. Shampine, J. F. Ervin, V. M. Payne, M. W. Massing, J. D. Kilts, J. L. Strauss, P. S. Calhoun, et al. Cerebrospinal Fluid Dehydroepiandrosterone Levels Are Correlated with Brain Dehydroepiandrosterone Levels, Elevated in Alzheimer's Disease, and Related to Neuropathological Disease Stage J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3173 - 3178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Laurine, D. Lafitte, C. Gregoire, E. Seree, E. Loret, S. Douillard, B. Michel, C. Briand, and J.-M. Verdier Specific Binding of Dehydroepiandrosterone to the N Terminus of the Microtubule-associated Protein MAP2 J. Biol. Chem., August 8, 2003; 278(32): 29979 - 29986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Strous, R. Maayan, R. Lapidus, R. Stryjer, M. Lustig, M. Kotler, and A. Weizman Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia Arch Gen Psychiatry, February 1, 2003; 60(2): 133 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Weill-Engerer, J.-P. David, V. Sazdovitch, P. Liere, B. Eychenne, A. Pianos, M. Schumacher, A. Delacourte, E.-E. Baulieu, and Y. Akwa Neurosteroid Quantification in Human Brain Regions: Comparison between Alzheimer's and Nondemented Patients J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5138 - 5143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Cardounel and J. L. Zweier Endogenous Methylarginines Regulate Neuronal Nitric-oxide Synthase and Prevent Excitotoxic Injury J. Biol. Chem., September 6, 2002; 277(37): 33995 - 34002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-J. Lai and D. P. McCobb Opposing actions of adrenal androgens and glucocorticoids on alternative splicing of Slo potassium channels in bovine chromaffin cells PNAS, May 28, 2002; 99(11): 7722 - 7727. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
